Efficacy of Autologous Platelet-Rich Plasma Therapy Versus Topical Minoxidil in Men With Moderate Androgenetic Alopecia: A Randomized Open-Label Trial

    February 2023 in “ Journal of Dermatological Treatment
    Mithinkumar Balasundaram, Rashmi Kumari, Sivaranjini Ramassamy
    From the encyclopedia
    Platelet-Rich Plasma →

    growth factors taken from your blood and injected into your scalp to stimulate hair

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Studysummary In this study, both platelet-rich plasma and minoxidil increased hair counts and density in moderate androgenetic alopecia in men, but patient satisfaction was higher with minoxidil, which also had fewer side effects.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This study compared the efficacy and safety of autologous Platelet-rich plasma (PRP) therapy to topical Minoxidil in treating moderate androgenetic alopecia (AGA) in men. Involving 64 participants aged 20-50, the trial found that 56% of those using Minoxidil and 38% of those receiving PRP showed improvement at week 24, though the difference was not statistically significant (p = 0.124). Both treatments increased hair count and density by week 12, but patient satisfaction was higher with Minoxidil. Adverse events were more common with PRP (53%) compared to Minoxidil (37%). The study concludes that while PRP is effective, it may not differ significantly from Minoxidil in treating moderate AGA.
    Discuss this study in the Community →

    Research cited in this study

    15 / 15 results